Interestingly, the gut metabolic module aspartate degradation I, which converts L-aspartate to oxaloacetate by aspartate aminotransferase, was elevated in SAD patients and the authors hypothesized that bacterial aspartate aminotransferase enzyme activity may represent a link between gut microbiome function and the tryptophan-kynurenine pathway, a key physiological system in psychiatric disorders (Butler et al., 2023)
Key Performance Benefits
My weight has started to go down
2.Keep out of reach of children to prevent accidental ingestion
[Google Scholar] Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, Schafers KP, Luscher TF, Camici PG
Foundayo (orforglipron) Foundayo ( orforglipron ) is a once-daily oral GLP-1 medication that was FDA-approved for chronic weight management in April 2026